2019 American Transplant Congress
What Do We Not Know about Long Term Liver Transplant Patients? A Look at Side Effect Burden and Medication Adherence
*Purpose: Historically our focus in transplantation has been on 1 year patient and graft outcomes. With the proposed shifts in legislation and the more recent…2019 American Transplant Congress
Hepatic Stellate Cells and Liver Derived Endothelial Cells Improve Scaffold-Free 3D-Bioprintied Liver Model
*Purpose: Hepatic stellate cells (HSC) comprise about 2-8% of liver cells and are vital to hepatocellular function. Scaffold-free 3D-bioprinting (SF3DBP) allows creation of realistic tissue…2019 American Transplant Congress
Hepatitis C Treatment and Transplant Outcomes in Liver Transplant Recipients with Hepatitis C Positive Donors
University of Maryland Medical Center, Baltimore, MD
*Purpose: With direct-acting antivirals for hepatitis C virus (HCV), transplant centers have expanded the donor pool with positive short term outcomes with early HCV treatment.…2019 American Transplant Congress
No Plan is a Bad Plan! Results of the American Society of Transplantation (AST) Living Donor Community of Practice Mortality Workgroup Survey on Disaster Planning Following a Living Donor Death
*Purpose: The risk of perioperative mortality following living kidney and liver donation, although extremely low, must not be considered a ‘never event’. While the risks…2019 American Transplant Congress
Sensitivity of 5-Tier System to Unadjusted Confounding
*Purpose: The Scientific Registry of Transplant Recipients (SRTR) fits risk-adjusted models for its semiannual program-specific reports (PSRs). Although SRTR adjusts for as many important risk…2019 American Transplant Congress
Exercise for Solid Organ Transplant Candidates and Recipients: A Joint Position Statement of the Canadian Society of Transplantation (CST) and Canadian Network for Rehabilitation and Exercise for Solid Organ Transplant Optimal Recovery (CAN-RESTORE)
*Purpose: Exercise training has been shown to be beneficial across several chronic disease groups that may lead to solid organ transplantation (SOT), and across organ…2019 American Transplant Congress
Sirna Uptake During Ex Vivo Hypothermic And Normothermic Liver Machine Perfusion: Beginning Of A New Era Of Organ Preservation
*Purpose: RNA interference (RNAi) is a natural gene modulation process that was recently approved for clinical use and has great potential for treatment of many…2019 American Transplant Congress
Differentiation and Characterization of Human Endodermal Precursors for Liver Cell Therapies
*Purpose: Mouse pluripotent stem cell (PSC)-derived endoderm precursors (EPs) have small size, endoderm lineage gene expression signatures, and high proliferation rates, that allow engraftment in…2019 American Transplant Congress
Outcomes Following Open Inguinal Hernia Repair in Liver Transplant versus Cirrhotic Patients
*Purpose: Patients with cirrhosis are at an increased risk for post-operative complications after open inguinal hernia repair (OIHR). Conversely, liver transplant recipients (LTR) may have…2019 American Transplant Congress
Performance Improvement Initiative: Ambulatory Tool to Improve Tacrolimus Intrapatient Variability (IPV) Monitoring in Kidney & Liver Transplant Recipients
1University of Cincinnati, Cincinnati, OH, 2UC Health, Cincinnati, OH
*Purpose: High tacrolimus (TAC) intrapatient variability (IPV) is associated with poorer outcomes. Manual monitoring of TAC IPV is labor intensive and not always feasible. As…
- « Previous Page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- …
- 50
- Next Page »